Table 3 Experience of pharmacists with doctors (N = 396)
Experience | Education | Agree | Disagree | P-Value | Type | Agree | Disagree | P-Value | Experience | Agree | Disagree | P-Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacists are a reliable source of general medicines information (i.e., specific facts about medicines, which can be found in standard references) | B/M Pharm | 70 (17.7%) | 17 (4.3%) | 0.000* | State funded | 180 (45.5%) | 19 (4.8%) | 0.016 | < 5 years | 68 (17.2%) | 0 (0%) | 0.000* |
Pharm.D | 286 (72.2%) | 9 (2.3%) | Private | 190 (48%) | 7 (1.8%) | 5–10 years | 224 (56.6%) | 12 (3.0%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 78 (19.7%) | 14 (3.5%) | ||||
Pharmacists routinely counsel patients regarding the safe and appropriate use of medicines | B/M Pharm | 72 (18.2%) | 15 (3.8%) | 0.002 | State funded | 181 (45.7%) | 18 (4.5%) | 0.606 | < 5 years | 64 (16.2%) | 4 (1.0%) | 0.007 |
Pharm.D | 277 (69.9%) | 18 (4.5%) | Private | 182 (46%) | 15 (3.8%) | 5–10 years | 222 (56.1%) | 14 (3.5%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 77 (19.4%) | 15 (3.8%) | ||||
Pharmacists routinely inform clinicians about the cost-effectiveness of therapy and give accurate advice regarding alternatives treatments | B/M Pharm | 55 (13.9%) | 32 (8.1%) | 0.000* | State funded | 171 (43.2%) | 28 (7.1%) | 0.005 | < 5 years | 63 (15.9%) | 5 (1.3%) | 0.004 |
Pharm.D | 249 (62.9%) | 46 (11.6%) | Private | 147 (37.1%) | 50 (12.6%) | 5–10 years | 189 (47.7%) | 47 (11.9%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 66 (16.7%) | 26 (6.6%) | ||||
Pharmacists are willing to take personal responsibility for resolving any medicines-related problems they discover | B/M Pharm | 73 (18.4%) | 14 (3.5%) | 0.000* | State funded | 180 (45.5%) | 19 (4.8%) | 0.008 | < 5 years | 67 (16.9%) | 1 (0.3%) | 0.001 |
Pharm.D | 284 (71.7%) | 11 (2.8%) | Private | 191 (48.2%) | 6 (1.5%) | 5–10 years | 225 (56.8%) | 11 (2.8%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 79 (19.9% | 13 (3.3%) | ||||
Pharmacists routinely inform clinicians if they discover clinical problems with prescriptions | B/M Pharm | 78 (19.7%) | 9 (2.3%) | 0.005 | State funded | 193 (48.7%) | 6 (1.5%) | 0.000* | < 5 years | 67 (16.9%) | 1 (0.3%) | 0.031 |
Pharm.D | 269 (67.9%) | 26 (6.6%) | Private | 163 (41.2%) | 34 (8.6%) | 5–10 years | 209 (52.8%) | 27 (6.8%) | ||||
Overseas | 9 (2.3%) | 5 (1.3%) | – | – | – | > 10 years | 80 (20.2%) | 12 (3.0%) | ||||
Pharmacists frequently ask to clarify therapeutic objectives clinicians have for patients | B/M Pharm | 56 (14.1%) | 31 (7.8%) | 0.000* | State funded | 169 (42.7%) | 30 (7.6%) | 0.047 | < 5 years | 64 (16.2%) | 4 (1.0%) | 0.000* |
Pharm.D | 279 (70.5%) | 16 (4.0%) | Private | 180 (45.5%) | 17 (4.3%) | 5–10 years | 220 (55.6%) | 16 (4.0%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 65 (16.4%) | 27 (6.8%) | ||||
Pharmacists frequently let medics know that patients have experienced some problem with their medications | B/M Pharm | 71 (17.9%) | 16 (4.0%) | 0.000* | State funded | 172 (43.4%) | 27 (6.8%) | 0.035 | < 5 years | 65 (16.4%) | 3 (0.8%) | 0.001 |
Pharm.D | 275 (69.4%) | 20 (5.1%) | Private | 183 (46.2%) | 14 (3.5%) | 5–10 years | 217 (54.8%) | 19 (4.8%) | ||||
Overseas | 9 (2.3%) | 5 (1.3%) | – | – | – | > 10 years | 73 (18.4%) | 19 (4.8%) | ||||
Pharmacists are focused on ensuring the safety of patients with respect to the therapeutic use of medicines | B/M Pharm | 70 (17.7%) | 17 (4.3%) | 0.014 | State funded | 184 (46.5%) | 15 (3.8%) | 0.023 | < 5 years | 66 (16.7%) | 2 (0.5%) | 0.008 |
Pharm.D | 270 (68.2%) | 25 (6.3%) | Private | 168 (42.4%) | 29 (7.3%) | 5–10 years | 211 (53.3%) | 25 (6.3%) |  | |||
Overseas | 12 (3.0%) | 2 (0.5%) | – | – | – | > 10 years | 75 (18.9%) | 17 (4.3%) |  | |||
Pharmacists respect the autonomy of patients and act to promote the concept of concordance | B/M Pharm | 73 (18.4%) | 14 (3.5%) | 0.000* | State funded | 181 (45.7%) | 18 (4.5%) | 0.025 | < 5 years | 66 (16.7%) | 2 (0.5%) | 0.002 |
Pharm.D | 284 (71.7%) | 11 (2.8%) | Private | 190 (48%) | 7 (1.8%) | 5–10 years | 226 (57.1%) | 10 (2.5%) | ||||
Overseas | 14 (3.5%) | 0 (0%) | – | – | – | > 10 years | 79 (19.9%) | 13 (3.3%) | ||||
Pharmacists are practicing as autonomous clinicians | B/M Pharm | 77 (19.4%) | 10 (2.5%) | 0.005 | State funded | 173 (43.7%) | 26 (6.6%) | 0.075 | < 5 years | 65 (16.4%) | 3 (0.8%) | 0.021 |
Pharm.D | 269 (67.9%) | 26 (6.6%) | Private | 182 (46%) | 15 (3.8%) | 5–10 years | 214 (54.0%) | 22 (5.6%) | ||||
Overseas | 9 (2.3%) | 5 (1.3%) | – | – | – | > 10 years | 76 (19.2%) | 16 (4.0%) |